Wave Life Sciences WVE Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Wave Life Sciences’s reported figures.
Based on trailing twelve months.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's free cash flow yield?
- Wave Life Sciences (WVE) reported free cash flow yield of -13.6% in Q1 2026.
- How has Wave Life Sciences's free cash flow yield changed year-over-year?
- Wave Life Sciences's free cash flow yield increased by 7.3% year-over-year, from -14.6% to -13.6%.
- What is the long-term trend for Wave Life Sciences's free cash flow yield?
- Over 4 years (2020 to 2025), Wave Life Sciences's free cash flow yield has grown at a -30.4% compound annual growth rate (CAGR), from -25.3% to -6%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.